Tozatto-Maio et al. recently reported in an international SCD cohort from Brazil, France and Senegal that a Toll-like receptor 2 (TLR2)genetic variant modulates occurrence of bacterial infections in SCD patients [45]. This evidence concerns the gene TLR2 and bacterial infectious disease.